Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass–induced inflammation in humans
Open Access
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 110 (6) , 1658-1662
- https://doi.org/10.1016/s0022-5223(95)70027-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Glucocorticoids Blunt Neutrophil CD11b Surface Glycoprotein Upregulation During Cardiopulmonary Bypass in HumansAnesthesia & Analgesia, 1994
- Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenatorsThe Annals of Thoracic Surgery, 1993
- Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cellsMolecular Immunology, 1993
- Platelet protection by low-dose aprotinin in cardiopulmonary bypass: Electron microscopic studyThe Annals of Thoracic Surgery, 1993
- Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion.Journal of Clinical Investigation, 1992
- Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1992
- DOES APROTININ INHIBIT CARDIOPULMONARY BYPASSINDUCED INFLAMMATION?Anesthesiology, 1992
- Effect of aprotinin on neutrophil function after major vascular surgeryBritish Journal of Surgery, 1992
- Natural and synthetic antifibrinolytics in cardiac surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1992